{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:12:26Z","timestamp":1783098746030,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jns.2024.123226","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T03:24:35Z","timestamp":1725938675000},"page":"123226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cerebrospinal fluid soluble CD27 is a sensitive biomarker of inflammation in autoimmune encephalitis"],"prefix":"10.1016","volume":"466","author":[{"given":"Stefan","family":"Cobanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Blaabjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Scheller","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Henrik","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kondziella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Buhelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie Reith","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Sellebjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Romme Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123226_bb0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/B978-0-12-802395-2.00020-1","article-title":"Immune-mediated disorders","volume":"145","author":"H\u00f6ftberger","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2024.123226_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00804","article-title":"Cerebrospinal fluid findings in patients with autoimmune encephalitis-a systematic analysis","volume":"10","author":"Blinder","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0025","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001086","article-title":"CSF findings in acute NMDAR and LGI1 antibody-associated autoimmune encephalitis","volume":"8","author":"D\u00fcrr","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jns.2024.123226_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.00706","article-title":"Systematic review: syndromes, early diagnosis, and treatment in autoimmune encephalitis","volume":"9","author":"Hermetter","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0040","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0045","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jns.2024.123226_bb0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2024.123226_bb0055","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/ene.13324","article-title":"Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies \u2013 a national cohort study","volume":"24","author":"Celicanin","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0060","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14581\/jer.16010","article-title":"The laboratory diagnosis of autoimmune encephalitis","volume":"6","author":"Lee","year":"2016","journal-title":"J. Epilepsy Res."},{"key":"10.1016\/j.jns.2024.123226_bb0075","article-title":"NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study","author":"Nissen","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0080","first-page":"496","article-title":"The CD27-CD70 pathway and pathogenesis of autoimmune disease, Semin","volume":"45","author":"Han","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2024.123226_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.coviro.2016.12.001","article-title":"The role of CD27 in anti-viral T-cell immunity","volume":"22","author":"Grant","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jns.2024.123226_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.24408","article-title":"Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis","volume":"78","author":"Komori","year":"2015","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123226_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.147.1.29","article-title":"A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR\/CD3 complex","volume":"147","author":"Hintzen","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jns.2024.123226_bb0100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1177\/1352458518774880","article-title":"CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage","volume":"25","author":"Romme Christensen","year":"2019","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jns.2024.123226_bb0105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/acn3.293","article-title":"Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis","volume":"3","author":"Komori","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jneuroim.2019.03.015","article-title":"Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory disease","volume":"332","author":"Feresiadou","year":"2019","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2024.123226_bb0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/jamaneurol.2016.4997","article-title":"Soluble CD27 levels in cerebrospinal fluid as a prognostic biomarker in clinically isolated syndrome","volume":"74","author":"Van Der Vuurst De Vries","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102391","article-title":"Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis","volume":"45","author":"Mahler","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2024.123226_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8333","article-title":"\u03b3-Secretase directly sheds the survival receptor BCMA from plasma cells","volume":"6","author":"Laurent","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jns.2024.123226_bb0130","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ana.25083","article-title":"Molecular-based diagnosis of multiple sclerosis and its progressive stage","volume":"82","author":"Barbour","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0135","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/neuonc\/nox097","article-title":"Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma","volume":"19","author":"Thaler","year":"2017","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jns.2024.123226_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 Guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jns.2024.123226_bb0145","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/1352458513488232","article-title":"Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis","volume":"19","author":"Teunissen","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jns.2024.123226_bb0150","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1212\/WNL.0b013e3181c47cc2","article-title":"A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking","volume":"73","author":"Teunissen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123226_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0193492","article-title":"Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington\u2019s disease","volume":"13","author":"Niemel\u00e4","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2024.123226_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578128","article-title":"Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis","volume":"381","author":"El Mahdaoui","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2024.123226_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-024-03077-9","article-title":"Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis","volume":"21","author":"Cencioni","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2024.123226_bb0170","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.25173","article-title":"N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0175","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/brain\/awac088","article-title":"Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis","volume":"145","author":"Al-Diwani","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jns.2024.123226_bb0180","article-title":"Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis","volume":"121","author":"Theorell","year":"2024","journal-title":"PNAS Proc. Natl. Acad. Sci. United States Am."},{"key":"10.1016\/j.jns.2024.123226_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2019.00116","article-title":"Elevated serum and cerebrospinal fluid CD138 in patients with anti-N-methyl-d-aspartate receptor encephalitis","volume":"12","author":"Zhu","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jns.2024.123226_bb0190","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123226_bb0195","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/brain\/aww208","article-title":"Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis","volume":"139","author":"Kreye","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jns.2024.123226_bb0200","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/NDT.S246085","article-title":"CXCL13 is a biomarker of anti-leucine-rich glioma-inactivated protein 1 encephalitis patients","volume":"16","author":"Lin","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jns.2024.123226_bb0205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0161656","article-title":"Utility of CSF cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2024.123226_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-016-0507-9","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid","volume":"13","author":"Liba","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2024.123226_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00904","article-title":"Elevated soluble Fas and FasL in cerebrospinal fluid and serum of patients with anti-N-methyl-D-aspartate receptor encephalitis","volume":"9","author":"Ding","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00727","article-title":"Elevation of YKL-40 in the CSF of anti-NMDAR encephalitis patients is associated with poor prognosis","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0230","doi-asserted-by":"crossref","first-page":"e2546","DOI":"10.1212\/WNL.0000000000011937","article-title":"Prospective quantification of CSF biomarkers in antibody-mediated encephalitis","volume":"96","author":"Day","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123226_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2018.00668","article-title":"Biomarkers of neurodegeneration in autoimmune-mediated encephalitis","volume":"9","author":"K\u00f6rtvelyessy","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2024.123226_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000669","article-title":"Intrathecal B-cell activation in LGI1 antibody encephalitis","volume":"7","author":"Lehmann-Horn","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:05:45Z","timestamp":1741064745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24003617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":48,"alternative-id":["S0022510X24003617"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123226","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid soluble CD27 is a sensitive biomarker of inflammation in autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123226"}}